Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Marc Cobo

At a glance: Marc Cobo is Principal Accounting Officer at BridgeBio Oncology Therapeutics (BBOT). Their latest SEC Form 4, filed Nov 17, 2026, reported a sale of $185. On file: 0 purchase lines ($0) and 1 sale line ($185).

Disclosed holdings: about $25K of BBOT stock: 13,734 shares reported on their latest Form 4 (filed Nov 17, 2026), valued at the Nov 20, 2026 close of $1.82. This counts only BBOT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $185

Reported trades

Filed Stock Type Shares Price Value Since
Nov 17SEC BBOTBridgeBio Oncology Therapeutics, Inc. Sell Plan 7813,734 held (−1%) $2.37 $185 -23.2%
  • Sell

    Principal Accounting Officer Marc Cobo sold $185 of BBOT at $2.37 — pre-scheduled 10b5-1 plan sale.

Follow Marc Cobo

Get one email when Marc Cobo files a new purchase or sale. Free.

At most one email a day about Marc Cobo, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.